EVALUATIONOFRENAL REPLACEMENT THERAPYQUALITY IN UKRAINE: TIME FOR ACTIONS

Mykola Kolesnyk; Nadiya Kozlyuk

doi:10.31450/ukrjnd.2(46).2015.01

Mykola Kolesnyk State Institution «Institute of Nephrology of National Academy Medical Sciences of Ukraine»
Nadiya Kozlyuk Ukrainian Renal Registry

DOI: https://doi.org/10.31450/ukrjnd.2(46).2015.01

Keywords: end-stage renal disease, epidemiology, mortality, renal replacement therapy, Ukraine.

Abstract

Background. Little is known about the status of renal replacement therapy (RRT) in the post-Soviet period of Ukraine. We therefore investigated the epidemiology and treatment outcomes of RRT in Ukrainian patients and put the results into an international perspective.

Methods. Data from the Ukrainian National Renal Registry for patients on RRT between 1 January 2010 and 31 December 2012 were selected. We calculated the incidence and prevalence of RRT per million population (pmp) and the 3-, 12- and 24-month patient survival using the Kaplan— Meier method and Cox regression

Results. There were 5985prevalent patients on RRT on 31 December 2012 (131,2 pmp). Mean age was 46,5 ± 13,8 years, 56% were men and 74% received haemodialysis (HD), while peritoneal dialysis and kidney transplantation both represented 13%. The most common cause of end-stage renal disease was glomerulonephritis (51%), while only 12% had diabetes. In 2012, 1129 patients started dialysis (incidence 24,8 pmp), with 80% on HD. Mean age was 48 ± 14 years, 58% were men and 20% had diabetes. Three, 12- and 24-month patient survival on dialysis was 95,1%, 86,0% and 76,4%, respectively. The transplant rate in 2012 was 2,1 pmp.

Conclusions. The incidence and prevalence of RRT and the transplantation rate in Ukraine are among the lowest in Europe, suggesting that the need for RRT is not being met. Strategies to reduce the RRT deficit include the development and improvement of transplantation and home-based dialysis programs. Further evaluation of the quality of Ukrainian RRT care is needed.

Downloads

Download data is not yet available.

References

Caskey F. J. Exploring.the differences in epidemiology of treated ESRD between Germany and England and Wales / H. J. Schober-Halstenberg, P. J. Roderick [et al.] // Am. J. Kidney Dis. - 2006. - Vol. 47. - P. 445-454.

Caskey F. J. Global variation in renal replacement therapy for end-stage renal disease / A. Kramer, R. F. Elliott [et al.] // Nephrol. Dial.Transplant. – 2011. – Vol. 26. – P. 2604-2610.

Couchoud C. From registry data collection to international comparisons: examples of haemodialysis duration and frequency / J. Kooman, P. Finne [et al.] // Nephrol. Dial. Transplant. - 2009. - Vol. 24. - P. 217-224.

De Vecchi A. F. Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies / M. Dratwa, M. E. Wiedemann // Nephrol. Dial. Transplant. - 1999. - Vol. 14, Supp l 6. - P. 31-41.

Dor A. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) / M. V. Pauly, M. A. Eichleay [et al.] // Int. J. Health. Care Finance Econ. - 2007. - Vol. 7. - P. 73-111.

ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2011. Academic Medical Center, Department of Medical Informatics. Amsterdam, The Netherlands, 2013.

Fenton S. S. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates / D. E. Schaubel, M. Desmeules [et al.] // Am. J. Kidney Dis. - 1997. - Vol 30. - P. 334-342.

Grassmann A. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends / S. Gioberge, S. Moeller [et al.] // Nephrol. Dial. Transplant. - 2005. - Vol. 20. - P. 2587-2593.

Heaf J. G. Initial survival advantage.of peritoneal dialysis relative to haemodialysis / H. Lokkegaard, M. Madsen // Nephrol. Dial.Transplant. - 2002. - Vol. 17. - P. 112-117.

Horl W. H. Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: access to ESRD treatments / F. de Alvaro, P. F. Williams // Nephrol. Dial. Transplant. - 1999. - Vol. 14, Suppl 6. - P. 10-15.

Kramer A. Exploring the association between macroeconomic indicators and dialysis mortality / V. S. Stel, F. J. Caskey [et al.] // Clin. J. Am. Soc. Nephrol. - 2012. - Vol. 7. - P. 1655-1663.

Kramer A. Renal replacement therapy in Europe–a summary of the 2010 ERA-EDTA Registry Annual Report / V. S. Stel, J. M. Abad Diez [et al.] // Clin. Kidney J. - 2013. - Vol. 6. - P. 105-115.

Levey A. S. Chronic kidney disease: common, harmful, and treatable–World Kidney Day 200 / S. P. Andreoli, T. DuBose [et al.] // Clin. J. Am. Soc. Nephrol. - 2007. - Vol. 2. - P. 401-405.

Liem Y. S. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands / J. B. Wong, M. G. Hunink [et al.] // Kidney Int. - 2007. - Vol. 71. - P. 153-158.

Locatelli F. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) / R. L. Pisoni, C. Combe [et al.] // Nephrol. Dial. Transplant . – 2004. – Vol. 19. – P. 121132.

MuntnerP. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease / J. Coresh, N. R. Powe [et al.] // J. Am. Soc. Nephrol. – 2003. - Vol. 14. - P. 1568-1577.

PortF. K. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study / R. L. Pisoni, J. Bommer [et al.] // Clin. J. Am.Soc. Nephrol. - 2006. - Vol. 1. - P. 246-255.

Tentori F. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) / M. J. Blayney, J. M. Albert [et al.] // Am. J. Kidney Dis. - 2008. - Vol. 52. - P. 519-530.

Tentori F. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study / J.M. Albert, E. W. Young [et al.] // Nephrol. Dial. Transplant. - 2009. - Vol. 24. - P. 963-972.

U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and EndStage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.

Van de Luijtgaarden M. W. M. Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists / M. Noordzij, C. Tomson [et al.] // Am. J. Kidney Dis. – 2012. – Vol. 60. - P. 940-948.

Van Dijk P. C. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe / A. H. Zwinderman, F. W. Dekker [et al.] // Kidney Int. - 2007. - Vol. 71. - P. 53-59.

Van Manen J. G. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy / P. C. van Dijk, V. S. Stel [et al.] // Nephrol. Dial. Transplant. - 2007. - Vol. 22. - P. 187-195.

Vonesh E. F. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis / J. J. Snyder, R. N. Foley [et al.] // Kidney Int. - 2004. - Vol. 66. - P. 2389-2401.